Protective effect of palmitoylethanolamide, a naturally-occurring molecule, in a rat model of cystitis
Federica Pessina, Raffaele Capasso, Francesca Borrelli, Teresa Aveta, Lorena Buono, Giuseppe Valacchi, Paolo Fiorenzani, Vincenzo Di Marzo, Pierangelo Orlando, Angelo A. Izzo
Index: J. Urol. 193(4) , 1401-8, (2015)
Full Text: HTML
Abstract
Purpose Palmitoylethanolamide is both an endogenous mediator released together with the endocannabinoid anandamide from membrane phospholipids, and a plant-derived compound with analgesic and antinflammatory properties. Here, we verified if the pathophysiology of experimental cystitis involves changes in the levels of palmitoylethanolamide and of some of its targets [i.e. cannabinoid (CB1 and CB2) receptors, and PPARα] and if exogenous-administered palmitoylethanolamide can be proposed as a preventive measure for cystitis.
Related Compounds
Related Articles:
2015-04-01
[Thromb. Haemost. 113(4) , 838-50, (2015)]
On the effects of CP 55-940 and other cannabinoid receptor agonists in C6 and U373 cell lines.
2015-10-01
[Toxicol. In Vitro 29 , 1941-51, (2015)]
2015-07-01
[Neurobiol. Dis. 79 , 41-50, (2015)]
2011-01-01
[PLoS ONE 6(2) , e16957, (2011)]
2015-02-01
[Phytochemistry 110 , 58-71, (2015)]